E Fund Management (HK)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Buy
3,249
+2,975
+1,086% +$154K 0.08% 148
2026
Q1
$13.9K Buy
+274
New +$12.8K 0.01% 279
2024
Q4
Sell
-3
Closed 179
2024
Q3
$0 Hold
3
﹤0.01% 154
2024
Q2
$0 Buy
+3
New +$380 ﹤0.01% 144

Other funds holding MRNA

E Fund Management (HK)'s MRNA Position: Q2 2026 in Review

E Fund Management (HK) increased its Moderna (MRNA) stake by 1,086% in Q2 2026, buying an estimated $154K and bringing the position to 3,249 shares worth $228K. The position accounts for 0.08% of the portfolio, ranked #148.

E Fund Management (HK) first reported a position in MRNA in Q2 2024 and has held it in 4 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • E Fund Management (HK) held 3,249 shares of Moderna worth $228K as of Q2 2026.
  • E Fund Management (HK) bought 2,975 Moderna shares in Q2 2026, an estimated $154K.
  • Moderna made up 0.08% of E Fund Management (HK)'s portfolio in Q2 2026, its #148 holding.
  • E Fund Management (HK) first reported a position in Moderna in Q2 2024 and has held it in 4 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.